drugset / Trial / NCT01874015
Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is a prospective, randomized, parallel, phase 1 trial to assess the safety and feasibility of the transplantation of bone marrow derived mesenchymal stem cells (MSCs) in fistulizing Crohn's disease.
Timeline
- Start
- 2013-02
- Primary completion
- 2017-12
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | fibroblasts | Cell therapy | — | Other |
| Comparator | mesenchymal stem cells | Cell therapy | — | Other |